Article
Transient muscle expression of mitoARCUS in mice leads to sustained reductions in pathogenic mtDNA and reduces fatigability.
Molecular therapy : the journal of the American Society of Gene Therapy - 1 Apr 2026
Bacman Sandra R, Shoop Wendy, Henley-Beasley C Spencer, Thompson Rhese, Barrera-Paez Jose Domingo, Theard Lise-Michelle, Rodriguez-Silva Monica, Gorsuch Cassandra, Barton Elisabeth R, Moraes Carlos T
Abstract excerpt
Mitochondrial myopathies are often caused by heteroplasmic mutations in the mitochondrial DNA (mtDNA). In muscle, biochemical, pathological, and clinical impairments are observed only when the ratios of mutant/wild-type mtDNA are high. Because reductions in mutant mtDNA loads are essentially permanent, we reasoned that transient expression of a therapeutic mitochondrial nuclease could be sufficient to permanently...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
